Clinical Trial Update: Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS [Phase 4]

View source ↗

Summary

Phase 4 trial reporting efficacy and safety of Neobianacid® for GERD and EPS has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Neobianacid®

Snippet

Sponsor: Aboca Spa Societa' Agricola | Conditions: GERD, EPS | Phase 4 | Status: COMPLETED